Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Pulmonary Hypertension

  Free Subscription


1 Am Heart J
1 Am J Med Sci
1 Am J Otolaryngol
1 Am J Physiol Heart Circ Physiol
1 Am J Respir Cell Mol Biol
2 Am J Respir Crit Care Med
1 bioRxiv
1 Cardiology
1 Cardiovasc Res
1 Circ Heart Fail
1 Clin Exp Hypertens
1 Clin Res Cardiol
1 Cochrane Database Syst Rev
1 Eur Heart J Cardiovasc Imaging
1 Eur Heart J Case Rep
1 Eur J Cardiothorac Surg
2 Front Cardiovasc Med
1 Front Pediatr
1 Heart Fail Clin
1 Heliyon
1 Int J Biochem Cell Biol
1 Int Urol Nephrol
4 J Am Heart Assoc
1 J Cardiopulm Rehabil Prev
1 J Cardiovasc Med (Hagerstown)
1 J Clin Immunol
1 J Fam Pract
1 J Heart Lung Transplant
1 J Pain Symptom Manage
2 J Pediatr
2 Liver Transpl
1 Mol Pharmacol
1 Pediatr Pulmonol
1 Pediatr Res
1 Pharmacol Ther
1 Pulm Circ
2 Respir Med
1 Respir Res
1 Toxicol Appl Pharmacol
1 Turk J Med Sci

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am Heart J

  1. BENINCASA G, Napoli C, Loscalzo J, Maron BA, et al
    Pursuing Functional Biomarkers in Complex Disease: Focus on Pulmonary Arterial Hypertension.
    Am Heart J. 2022 Dec 21:S0002-8703(22)00330-1. doi: 10.1016/j.ahj.2022.
    PubMed         Abstract available

    Am J Med Sci

  2. HEGAZY Y, Aryan M, Panchani N, Reif M, et al
    The correlation in echocardiogram to right heart catheterization in identifying pulmonary hypertension as a barrier to liver transplantation.
    Am J Med Sci. 2023 Mar 16:S0002-9629(23)01070.
    PubMed         Abstract available

    Am J Otolaryngol

  3. MONTALBARON MB, Tian L, Yu VX, Awad MI, et al
    Multi-institutional search for patient factors associated with adverse events following tracheotomy.
    Am J Otolaryngol. 2023;44:103773.
    PubMed         Abstract available

    Am J Physiol Heart Circ Physiol

  4. BROWN RD, Hunter KS, Li M, Frid MG, et al
    Functional and Molecular Determinants of Right Ventricular Response to Severe Pulmonary Hypertension in a Large Animal Model.
    Am J Physiol Heart Circ Physiol. 2023 Mar 24. doi: 10.1152/ajpheart.00614.2022.
    PubMed         Abstract available

    Am J Respir Cell Mol Biol

  5. HU CJ, Laux A, Gandjeva A, Wang L, et al
    The Effect of HIF Inhibition on the Phenotype of Fibroblasts in Human and Bovine Pulmonary Hypertension.
    Am J Respir Cell Mol Biol. 2023 Mar 21. doi: 10.1165/rcmb.2022-0114.
    PubMed         Abstract available

    Am J Respir Crit Care Med

    Cardiopulmonary Pathogenic Networks: Unveiling the Gut-Lung Microbiome Axis in Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2023;207:655-657.

  7. MOUTSOGLOU DM, Tatah J, Prisco SZ, Prins KW, et al
    Pulmonary Arterial Hypertension Patients Have a Proinflammatory Gut Microbiome and Altered Circulating Microbial Metabolites.
    Am J Respir Crit Care Med. 2023;207:740-756.
    PubMed         Abstract available


  8. JANI V, Aslam MI, Fenwick AJ, Ma W, et al
    Right Ventricular Sarcomere Contractile Depression and the Role of Thick Filament Activation in Human Heart Failure with Pulmonary Hypertension.
    bioRxiv. 2023 Mar 12:2023.03.09.531988. doi: 10.1101/2023.03.09.531988.
    PubMed         Abstract available


  9. LIN Y, Pang L, Huang S, Shen J, et al
    A nomogram for predicting 3-year mortality in patients with pulmonary hypertension due to left heart failure: A retrospective analysis of a prospective registry study.
    Cardiology. 2023 Mar 23. doi: 10.1159/000530206.
    PubMed         Abstract available

    Cardiovasc Res

  10. FAYYAZ AU, Sabbah MS, Dasari S, Griffiths LG, et al
    Histologic and proteomic remodeling of the pulmonary veins and arteries in a porcine model of chronic pulmonary venous hypertension.
    Cardiovasc Res. 2023;119:268-282.
    PubMed         Abstract available

    Circ Heart Fail

  11. MARTENS P, Bhattacharya S, Longinow J, Ives L, et al
    Hemodynamic Profiling and Prognosis in Cardiac Amyloidosis.
    Circ Heart Fail. 2023 Jan 25:e010078. doi: 10.1161/CIRCHEARTFAILURE.122.010078.
    PubMed         Abstract available

    Clin Exp Hypertens

  12. DONG J, Jiang XM, Xie DJ, Luo J, et al
    Establishment of a canine model of pulmonary arterial hypertension induced by dehydromonocrotaline and ultrasonographic study of right ventricular remodeling.
    Clin Exp Hypertens. 2023;45:2190503.
    PubMed         Abstract available

    Clin Res Cardiol

  13. BOXHAMMER E, Kletzer J, Kellermair J, Scharinger B, et al
    CT measured pulmonary artery to ascending aorta ratio stratified by echocardiographically obtained systolic pulmonary artery pressure values for noninvasive detection of pulmonary hypertension in patients with severe aortic valve stenosis.
    Clin Res Cardiol. 2023 Mar 20. doi: 10.1007/s00392-023-02182.
    PubMed         Abstract available

    Cochrane Database Syst Rev

  14. MORRIS NR, Kermeen FD, Jones AW, Lee JY, et al
    Exercise-based rehabilitation programmes for pulmonary hypertension.
    Cochrane Database Syst Rev. 2023;3:CD011285.
    PubMed         Abstract available

    Eur Heart J Cardiovasc Imaging

  15. KNIGHT DS, Karia N, Cole AR, Maclean RH, et al
    Distinct cardiovascular phenotypes are associated with prognosis in systemic sclerosis: a cardiovascular magnetic resonance study.
    Eur Heart J Cardiovasc Imaging. 2023;24:463-471.
    PubMed         Abstract available

    Eur Heart J Case Rep

  16. TAMURA H, Hosokawa S, Yuba K, Kishi K, et al
    Rescue balloon pulmonary angioplasty for worsening chronic thromboembolic pulmonary hypertension with essential thrombocythaemia and the JAK2-V617F mutation: a case report.
    Eur Heart J Case Rep. 2023;7:ytad106.
    PubMed         Abstract available

    Eur J Cardiothorac Surg

  17. VAN RAEMDONCK D, Vos R, Verleden GM, Ceulemans LJ, et al
    Living-donor lobar lung transplantation for pulmonary hypertension: living on the edge?
    Eur J Cardiothorac Surg. 2023 Mar 23:ezad097. doi: 10.1093.

    Front Cardiovasc Med

  18. ASLLANAJ B, Benge E, Bae J, McWhorter Y, et al
    Fluid management in septic patients with pulmonary hypertension, review of the literature.
    Front Cardiovasc Med. 2023;10:1096871.
    PubMed         Abstract available

  19. XIAO M, Lai D, Yu Y, Wu Q, et al
    Pathogenesis of pulmonary hypertension caused by left heart disease.
    Front Cardiovasc Med. 2023;10:1079142.
    PubMed         Abstract available

    Front Pediatr

  20. FUKASAWA Y, Yamamoto H, Ito M, Saito A, et al
    Case report: High-dose epoprostenol therapy in pediatric patients with pulmonary hypertension and developmental lung disease.
    Front Pediatr. 2023;11:1116434.
    PubMed         Abstract available

    Heart Fail Clin

  21. SCHUSTER M, Muller J, Schwarz EI, Saxer S, et al
    Oxygen Therapy in Pulmonary Vascular Disease: A Systematic Review, Meta-Analysis, and Comment.
    Heart Fail Clin. 2023;19.
    PubMed         Abstract available


  22. HUSSAIN T, Chai L, Wang Y, Zhang Q, et al
    Activation of PPAR-gamma prevents TERT-mediated pulmonary vascular remodeling in MCT-induced pulmonary hypertension.
    Heliyon. 2023;9:e14173.
    PubMed         Abstract available

    Int J Biochem Cell Biol

  23. XUN M, Zhang J, Wu M, Chen Y, et al
    Long non-coding RNAs: The growth controller of vascular smooth muscle cells in cardiovascular diseases.
    Int J Biochem Cell Biol. 2023;157:106392.
    PubMed         Abstract available

    Int Urol Nephrol

  24. BORBA GC, Andrade FP, de Souza Ferreira T, Pinotti AFF, et al
    Estimation of pulmonary artery systolic pressure in hemodialysis patients and its association with cardiorespiratory fitness and pulmonary function.
    Int Urol Nephrol. 2023;55:961-968.
    PubMed         Abstract available

    J Am Heart Assoc

  25. LAMMERS AE, Marek J, Diller GP, Haworth SG, et al
    Prognostic Value of Transthoracic Echocardiography in Children With Pulmonary Arterial Hypertension.
    J Am Heart Assoc. 2023;12:e023118.
    PubMed         Abstract available

  26. FORTMEIER V, Lachmann M, Unterhuber M, Stolz L, et al
    Epiphenomenon or Prognostically Relevant Interventional Target? A Novel Proportionality Framework for Severe Tricuspid Regurgitation.
    J Am Heart Assoc. 2023;12:e028737.
    PubMed         Abstract available

  27. CHANG KY, Giorgio K, Schmitz K, Walker RF, et al
    Effect of Chronic Digoxin Use on Mortality and Heart Failure Hospitalization in Pulmonary Arterial Hypertension.
    J Am Heart Assoc. 2023;12:e027559.
    PubMed         Abstract available

  28. XING Y, Qi J, Cheng X, Song X, et al
    Circ-myh8 Promotes Pulmonary Hypertension by Recruiting KAT7 to Govern Hypoxia-Inducible Factor-1alpha Expression.
    J Am Heart Assoc. 2023 Mar 21:e028299. doi: 10.1161/JAHA.122.028299.
    PubMed         Abstract available

    J Cardiopulm Rehabil Prev

  29. BARRET T, Degano B, Bouvaist H, Pison C, et al
    Routine Rehabilitation as a Treatment Component for Patients With Pulmonary Arterial or Chronic Thromboembolic Pulmonary Hypertensions.
    J Cardiopulm Rehabil Prev. 2023 Mar 21. doi: 10.1097/HCR.0000000000000755.
    PubMed         Abstract available

    J Cardiovasc Med (Hagerstown)

  30. ZUIN M, Bilato C, Rigatelli G, Quadretti L, et al
    Trends in age-specific and sex-specific pulmonary hypertension mortality in Italy between 2005 and 2017.
    J Cardiovasc Med (Hagerstown). 2023 Mar 20. doi: 10.2459/JCM.0000000000001457.
    PubMed         Abstract available

    J Clin Immunol

  31. FOGEL LA, Grady RM, He M, Kitcharoensakkul M, et al
    Steroid-Responsive Pulmonary Hypertension in a Pediatric Patient with Chronic Granulomatous Disease and Histoplasmosis.
    J Clin Immunol. 2023 Mar 24. doi: 10.1007/s10875-023-01473.

    J Fam Pract

  32. SINGH M, Berkey F, Fragin J, Grine K, et al
    Pulmonary hypertension: An update of Dx and Tx guidelines.
    J Fam Pract. 2023;72:72-83.
    PubMed         Abstract available

    J Heart Lung Transplant

  33. HUANG Y, Zhang QZ, Lv SJ
    Comments and opinions regarding "Riociguat and balloon pulmonary angioplasty improve prognosis in patients with inoperable chronic thromboembolic pulmonary Hypertension".
    J Heart Lung Transplant. 2023 Mar 20:S1053-2498(23)01788.

    J Pain Symptom Manage

  34. BROWN CE, Steiner JM, Leary PJ, Curtis JR, et al
    A World of Maximalist Medicine: Physician Perspectives on Palliative Care and End-of-life for Patients With Pulmonary Arterial Hypertension.
    J Pain Symptom Manage. 2023;65:e329-e335.
    PubMed         Abstract available

    J Pediatr

  35. FRANKLIN SD, Fierro J, Hysinger EB, Phinizy PA, et al
    Hemosiderin-Laden Macrophages in Bronchoalveolar Lavage Samples of Children with Bronchopulmonary Dysplasia.
    J Pediatr. 2023;253:79-85.
    PubMed         Abstract available

  36. LEVIN JC, Annesi CA, Williams DN, Abman SH, et al
    Discharge Practices for Infants with Bronchopulmonary Dysplasia: A Survey of National Experts.
    J Pediatr. 2022 Sep 17. pii: S0022-3476(22)00822.
    PubMed         Abstract available

    Liver Transpl

  37. KROWKA MJ, Kamath PS
    Portopulmonary hypertension: May we agree to disagree?
    Liver Transpl. 2023;29:349-350.

  38. JOSE A, Kopras EJ, Shah SA, Elwing JM, et al
    Portopulmonary hypertension practice patterns after liver transplantation.
    Liver Transpl. 2023;29:365-376.
    PubMed         Abstract available

    Mol Pharmacol

  39. GAO J, Yin H, Dong Y, Wang X, et al
    A Novel Role of Uricosuric Agent Benzbromarone in BK Channel Activation and Reduction of Airway Smooth Muscle Contraction.
    Mol Pharmacol. 2023;103:241-254.
    PubMed         Abstract available

    Pediatr Pulmonol

  40. UCROS S, Aparicio C, Castro-Rodriguez JA, Ivy D, et al
    High altitude pulmonary edema in children: A systematic review.
    Pediatr Pulmonol. 2023;58:1059-1067.
    PubMed         Abstract available

    Pediatr Res

  41. EL-KHUFFASH A, Mullaly R, McNamara PJ
    Patent ductus arteriosus, bronchopulmonary dysplasia and pulmonary hypertension-a complex conundrum with many phenotypes?
    Pediatr Res. 2023 Mar 18. doi: 10.1038/s41390-023-02578.

    Pharmacol Ther

  42. BEKEDAM FT, Goumans MJ, Bogaard HJ, de Man FS, et al
    Molecular mechanisms and targets of right ventricular fibrosis in pulmonary hypertension.
    Pharmacol Ther. 2023 Mar 18:108389. doi: 10.1016/j.pharmthera.2023.108389.
    PubMed         Abstract available

    Pulm Circ

  43. RAWLINGS GH, Novakova B, Armstrong I, Thompson AR, et al
    Can self-compassion help us better understand the impact of pulmonary hypertension on those with the condition and their carers? A cross-sectional analysis.
    Pulm Circ. 2023;13:e12208.
    PubMed         Abstract available

    Respir Med

  44. HELD M, Pfeuffer-Jovic E, Wilkens H, Guder G, et al
    Frequency and characterization of CTEPH and CTEPD according to the mPAP threshold > 20 mm Hg: Retrospective analysis from data of a prospective PE aftercare program.
    Respir Med. 2023;210:107177.
    PubMed         Abstract available

  45. CARLOZZI LN, Lee J, Barros LM, Buber Y, et al
    Establishing a balloon pulmonary angioplasty program for chronic thromboembolic pulmonary hypertension: A United States single-center experience.
    Respir Med. 2023 Mar 17:107215. doi: 10.1016/j.rmed.2023.107215.
    PubMed         Abstract available

    Respir Res

  46. YANG Z, Li P, Yuan Q, Wang X, et al
    Inhibition of miR-4640-5p alleviates pulmonary hypertension in chronic obstructive pulmonary disease patients by regulating nitric oxide synthase 1.
    Respir Res. 2023;24:92.
    PubMed         Abstract available

    Toxicol Appl Pharmacol

  47. ZHANG X, Yang Z, Su S, Nan X, et al
    Kaempferol ameliorates pulmonary vascular remodeling in chronic hypoxia-induced pulmonary hypertension rats via regulating Akt-GSK3beta-cyclin axis.
    Toxicol Appl Pharmacol. 2023;466:116478.
    PubMed         Abstract available

    Turk J Med Sci

  48. DUZGUN Z, Kayikcioglu LM, Aktan C, Bara B, et al
    Decreased circulating microRNA-21 and microRNA-143 are associated to pulmonary hypertension.
    Turk J Med Sci. 2023;53:130-141.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.